
Novel highly селективный covalent ингибитор of wild-type and gatekeeper mutant FGFR4, exhibiting excellent potency against FGFR4, FGFR4V550L, and FGFR4V550M with nanomolar activity in both the biochemical and клеточный assays while sparing FGFR1/2/3
Novel highly selective covalent inhibitor of wild-type and gatekeeper mutant FGFR4, exhibiting excellent potency against FGFR4, FGFR4V550L, and FGFR4V550M with nanomolar activity in both the biochemical and cellular assays while sparing FGFR1/2/3
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.